<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Harvey Group Practice</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Harvey Group Practice is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1307000C0&amp;denomIds=13.7&amp;selectedTab=summary">Formaldehyde</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Preparations for warts and calluses</td>
      <td>12</td>
      <td>0.08</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>8.71</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1307000C0AAALAL&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Formaldehyde (Buffered) 4% solution : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0203020R0&amp;denomIds=2.3.2&amp;selectedTab=summary">Propafenone hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>26</td>
      <td>Drugs for arrhythmias</td>
      <td>77</td>
      <td>0.34</td>
      <td>0.02</td>
      <td>0.05</td>
      <td>5.92</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0203020R0AAAAAA&amp;denomIds=2.3.2&amp;selectedTab=summary" target="_blank">Propafenone 150mg tablets : 26</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0803042E0&amp;denomIds=8.3.4&amp;selectedTab=summary">Cyproterone acetate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>21</td>
      <td>Prostate cancer and gonadorelin analogues</td>
      <td>41</td>
      <td>0.51</td>
      <td>0.03</td>
      <td>0.08</td>
      <td>5.91</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0803042E0AAAAAA&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Cyproterone 50mg tablets : 21</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1001010K0&amp;denomIds=10.1.1&amp;selectedTab=summary">Indometacin</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>73</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>887</td>
      <td>0.08</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>5.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1001010K0AAAAAA&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Indometacin 25mg capsules : 29</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1001010K0AAABAB&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Indometacin 50mg capsules : 44</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1108010Z0&amp;denomIds=11.8.1&amp;selectedTab=summary">Carbomer 974P</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Tear deficiency, eye lubricant/astringent</td>
      <td>88</td>
      <td>0.10</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>4.88</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1108010Z0AAAAAA&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Carbomer 974P 0.25% eye gel : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1108010Z0BBAAAA&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Liquivisc 0.25% eye gel : 6</a></div></td></tr></tbody></table>

        <h2>Prescribing where Harvey Group Practice is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=1305010I0&amp;denomIds=13.5.1&amp;selectedTab=summary">Gamolenic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Preparations for eczema</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.90</td>
      <td>0.30</td>
      <td>-3.03</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGBklEQVR4nO3da6gUZRzH8e8cxexmeTIrLzRdNCxIiELsZBalRRMFUhG9MRIkSnplOhX4IioGCpOEEEmxu9YLo5pUELzQxTdJUb0olQbMMk1JBK/pvxfPHDque/Ts9dlpfh8Y9pwFd3+s5zfPs7PPzAZmhoiUQ5fvACLSPiq8SImo8CIlosKLlIgKL1IiKrxIiajwIiWiwouUiAovUiIqvEiJNFb4INC6XJECGew7gIj0L4zTAOgBpgCTgKuyJJpY7+Op8CIdKIzTwcAjwLPAX8A64DVgeyOPq8KLdJgwTm8CVgA/AI9nSfR9sx5bhRfpEPmo/gLwGDA7S6JNzX4OFV6kA4RxOgxYBewGbs6S6GArnkcfy4l4FsbpWGATsAF4olVlB43wIl6FcToO+AJ4Pkuij1v9fCq8iCd52dcAT2dJtK4dz6kpvYgHYZxeS5vLDiq8SNuFcXoFkAJz2ll2UOFF2iqM04twZX8xS6K17X5+FV6kTcI4PQdYDbyXJdH7PjIEDV2XPggMs6B5cUT+n8I47QI+BHZmSTTXVw6N8CItlp8A8zpwHJjnM4s+lhNpvXnABOD+LIlO+gyiwou0UBinM4GHgTuzJDrmO48KL9IiYZzeB8TA1FYul62FCi/SAmGcTgIWA9OzJNrjO08vFV6kycI4vQ53RP6hLIl2+M7Tl47SizRRGKejgM9w57Nv9Z2nkgov0iRhnA7Hnfm2IEui9b7zVKPCizRBGKcX4647tzRLopW+8/RHhRdpUH61mrW4JbNv+s5zJiq8SAPCOO3GjewfZUn0hu88Z6PCi9QpjNPRuMtSvZsl0ULfeQZCH8uJ1CGM0/G4o/ELsiRa5TvPQGmEF6lRGKf34qbxc4pUdtAILzJg+Vlvc4GZwD1ZEv3iOVLNVHiRAQjj9HJgGe4U154siQ54jlQXFV7kDPJRfQbue91eBpZlSVTYb01W4UX6EcbpBGARrid3d9q6+Hqo8CIVwjgNgfnAXbjTW1cXeVTvq+Fr2oXzPx8JHAYOZ0l0olnBRNopn7rfAjwF3AYsBJZnSXTEa7Ama0bhfwTOzbcuwIB/gH2477Xem9/uAXYBO3u3LIkONRJepFH5t788iDvyvh94C1iZJdFxr8FapCVXrQ3jdAhwCTACuDTfRgJjgLH5NgYYCvxJn51An+13YJd2CtJM+emrPbhRfBpudvop8EGWRNt8ZmsHr5epDuN0EG5HMLZiGwOMAkbjZg77cbODXbgdwe78vsrtb72tKLcwTofy3wAzCrgauAa4HnchyX3A18CXwMYsiX7zFNWLjr8uff7eqhtX/t6dwGXA8Pz+btxsoju/bxBwDDiE23tXuz0GnARO5Fvfnyt/960TrvvvO0MADAHOww0AfW97f+4GLgCO4t4+7gX+AHYAvwI/AT9nSXS03eE7SUOFD4JgtpktbWKelipaXihe5qLlheJlbiRvo2vpZzf479utaHmheJmLlheKl7nuvDp5RqREVHiREmm08IV535MrWl4oXuai5YXiZa47b2NH6UWkUDSlFymRmk6eCYLgduBWYI+ZLQ+CYAZuUcN2M1vdioCNqpJ5JnADsMbMNvhNd7rKvPl9S4AVZrbFa7h+VHmNpwCTgS1mttlvutNVyTsLuBDAzBZ5DdePIAjuAJ40s0fz32fh1qNsMrOvBvo4tY7wk80swa1kAhhnZq8C42t8nHY6JbOZvQ0swa3A6kSn5M13qhu9Jjq7yr+LB3CLnLx+NfIZVOYdhCtPx3wHXCUz2wh81+euEWb2Cm6J8IDVWvjKN/xFOABwSsYgCM4HZgHv+IlzVpWv6Y24/9QeD1kGqjLzMDNbDEz3EWYAKvN2mdlzuNlqUdTVvZoO2uVTocm4detbgStxL9I2M/ukngCtViXzM8B2YL2ZfeMzWzWVec3s23w6d6TDp/SVfxchcMDMlnmMVlWVvFNxy3cPduqKuyAIJgIvAVtwg9U03Kxkcy1Teh2lFykRHaUXKREVXqREVHiRElHhRUpEhRcpERVepERUeJESUeFFSkSFFykRFV6kRFR4kRL5F8P6/CGx8QJUAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0&amp;denomIds=1.1.2&amp;selectedTab=summary">Alginic acid compound preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>225</td>
      <td>Compound Alginates and proprietary indigestion preparations</td>
      <td>233</td>
      <td>0.97</td>
      <td>1.00</td>
      <td>0.01</td>
      <td>-2.29</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0AAALAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg/5ml susp SF : 65</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0BEAIAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral suspension aniseed (Reckitt Benckiser) : 31</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0BEBEAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral susp peppermint (Reckitt Benckiser) : 65</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0BEAWAR&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Strawberry chewable tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0BIABAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid peppermint : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0BEAQAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance Mint chewable tablets (Reckitt Benckiser) : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0AAAPAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg chew tab SF : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0BEARA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action chewable tablets mint : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0BQACAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Acidex Advance oral suspension aniseed : 20</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0101021B0BEADAJ&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Infant oral powder sachets : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0704020AB&amp;denomIds=7.4.2&amp;selectedTab=summary">Solifenacin</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>39</td>
      <td>Drugs for urinary frequency enuresis and incontinence</td>
      <td>533</td>
      <td>0.07</td>
      <td>0.33</td>
      <td>0.12</td>
      <td>-2.20</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0704020ABAAAAAA&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Solifenacin 5mg tablets : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0704020ABAAABAB&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Solifenacin 10mg tablets : 25</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0107020J0&amp;denomIds=1.7.2&amp;selectedTab=summary">Hydrocortisone</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>11</td>
      <td>Copound haemorrhoidal preparations with corticosteroid</td>
      <td>66</td>
      <td>0.17</td>
      <td>0.58</td>
      <td>0.24</td>
      <td>-1.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0107020J0BEAAAE&amp;denomIds=1.7.2&amp;selectedTab=summary" target="_blank">Proctosedyl ointment : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0107020J0AAAGAG&amp;denomIds=1.7.2&amp;selectedTab=summary" target="_blank">Lidocaine 5% / Hydrocortisone acetate 0.275% ointment : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0107020J0BCAAAB&amp;denomIds=1.7.2&amp;selectedTab=summary" target="_blank">Anusol HC suppositories : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0107020J0BGAAAG&amp;denomIds=1.7.2&amp;selectedTab=summary" target="_blank">Xyloproct 5%/0.275% ointment : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0504010Y0&amp;denomIds=5.4.1&amp;selectedTab=summary">Quinine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>105</td>
      <td>Antimalarials</td>
      <td>160</td>
      <td>0.66</td>
      <td>0.89</td>
      <td>0.14</td>
      <td>-1.67</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAF+ElEQVR4nO3dbagUVRzH8e+5mpI3TfAhtMyhDCI1IX3j07Ui7WEgKApMAoVLEkSFQjS9CAtCpqAHKUKkpAd6Fb2InAotUiNTIg2yXkQPQ2bJLaubXk3LTi/OXNm77t6HvXf3zO78PnCYvbMy878PP8+Zs7NnjbUWESmGNt8FiEjjKPAiBaLAixSIAi9SIAq8SIEo8CIFosCLFIgCL1IgCrxIgSjwIgWiwIs/xui+7gYb7bsAEakuiJI24H7gOuBFYEcahzX/R6keXiSngiiZBCRAB/ASsB54ezjHVOBFciiIEgNsBXYCd6RxuA24GTh/OMdV4EXyaTUwBniqdwifbdcP56BG74cXb4yxWGt8l5E3QZRcCuwClqRxeHgkj60eXiR/NgEbRjrsoMCL5EoQJSuAKcDr9Ti+hvTij4b0fQRRMgY4ANydxuGBepxDPbxIfjwIfFyvsINuvBHJhSBKpgP3AfPreR718CL58CTuJbij9TyJengRz4IoWQzMAdbU+1wKvIhHQZS0A1uAe9I4PFPv82lIL+LXM8BbaRzuacTJ1MOLeBJEyW3APGBpo86pwIt4EETJNcDTwA1pHP7TqPNqSC/SYEGUBMCbwF1pHH7fyHMr8CINFETJ5cD7wPo0Dvc1+vwKvEiDZMP4HcC6NA6HtZBFrXQNL1Jn2WIWa4BHgVVpHO71VYsCL1JH2TJVm4BpwKI0Do/4rEeBF6mDrFdfCWwEXgBWN+LGmoEo8CIjLIiSBcCzQDdwfRqHP3gu6SwFXmSEBFEyF3gMmAU8lMbhdr8VnUuBFxmmIEquAjYAs4HHcbfK/ue3qsoUeJEaZNfoHcA64ArgCdwMvPfr9P4o8CJDEETJWOBOXNC7cW9+eTevPXo5BV5kAEGUjAKWAauAG4EPgc40Dr/wWlgNtIil+JPjRSyz1887gOXALcCXwBvAO2kc9visbTgUePEnJ4EPomQqbsWZ+cCCrP0L7AG2A9vrvfRUoyjw4k+DAx9EyXjcTPqcrM0FrgT+BA7iloj+DNifxuEfjaqrkRR48acOgc9mz6fhXgufhZtBn501gK9w4T6IG6Z/k8bhqZGsIc8UePGnhsAHUTIamA7MAC7JtjOAmcDlwGTgF+Bb4LtsexD4Oo3DYyNXfHNS4MUfY2zw8LaJwAVAe9Ym4T5qaQowteTxdOBiwAA/A4eAn7LtIeBHXLh/6/20VTmXXpaTQct613HAeODCrE2s8HgCfUPc23r3jQZs6g67D+gpaUeBX4EuIMVdU3cBR4DDaRyeru932drUwzehIEracJ8dPrZkW+1x6b5xFVp7lf2lrXehlDPACeA4bqKru8r2L1x4j9M3zD1Az9k13HIyS18kQ+rhgyi5qWxXpV+WGcZ2oOcM7o+v2tf9PTeUfzvSz7UB55W1MRX2VWpjsmYAW7I9lbXTQ3jcgwvsCVwwTwyincz77aIyeC3dwxtj1lprt/iuY6iase5mrBmas+7h1Nzqa9qt9V1AjZqx7masGZqz7pprbvXAi0gJBV6kQFo98E11bVaiGetuxpqhOeuuueaWnrQTkb5avYcXkRItd6edMaYDWAR0WWu3GmNW49448Z619iO/1VVWXnO2bzPwirXW24cW9KfCz3kpsBDYa63d7be66irU3Ym7cxBr7XNei+uHMeZa4F5r7crs607gImCXtfaTwR6nFXv4hdbaGHf/NdbaV4HNwGVeq+pfn5qNMbcDO71WNLA+NQO3AieBvC/1VF73KFxwuvyVNDBr7U6gdIWdydbajcCSoRynFQPfZ1LCGNMOdAKv+SlnUMonUq7G/SIXe6hlsMprnmCtfR5Y4aOYISivu81a+wjunXbNpKbJt5abtMuGbAuB34H9wAO4d1F9YK391Gdt1ZTXbK39PBvC/Z3zIX3pz3kmEADd1tqXPZbWrwp1L8Pdrnwsz3fcGWPm4VbG3YvrvJbjRia7hzKkb7nAi0h1rTikF5EqFHiRAlHgRQpEgRcpEAVepEAUeJECUeBFCkSBFykQBV6kQBR4kQJR4EUK5H8TyOeYvylkNgAAAABJRU5ErkJggg=="></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0504010Y0AAAFAF&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Quinine sulfate 200mg tablets : 66</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82084&amp;numIds=0504010Y0AAAHAH&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Quinine sulfate 300mg tablets : 39</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>